Daiwa Securities Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
90
| – | – | ﹤0.01% | 1246 |
|
|
2025
Q1 | $1K | Hold |
90
| – | – | ﹤0.01% | 1212 |
|
|
2024
Q4 | $2K | Hold |
90
| – | – | ﹤0.01% | 1210 |
|
|
2024
Q3 | $2K | Hold |
90
| – | – | ﹤0.01% | 1212 |
|
|
2024
Q2 | $2K | Hold |
90
| – | – | ﹤0.01% | 1233 |
|
|
2024
Q1 | $3K | Hold |
90
| – | – | ﹤0.01% | 1224 |
|
|
2023
Q4 | $3K | Hold |
90
| – | – | ﹤0.01% | 1229 |
|
|
2023
Q3 | $2K | Hold |
90
| – | – | ﹤0.01% | 1205 |
|
|
2023
Q2 | $3K | Sell |
90
-4,019
| -98% | -$134K | ﹤0.01% | 1203 |
|
|
2023
Q1 | $98K | Buy |
4,109
+789
| +24% | +$18.8K | ﹤0.01% | 991 |
|
|
2022
Q4 | $56K | Sell |
3,320
-1,540
| -32% | -$26K | ﹤0.01% | 1019 |
|
|
2022
Q3 | $72K | Sell |
4,860
-1,044
| -18% | -$15.5K | ﹤0.01% | 1027 |
|
|
2022
Q2 | $93K | Buy |
5,904
+2,401
| +69% | +$37.8K | ﹤0.01% | 1027 |
|
|
2022
Q1 | $94K | Buy |
3,503
+1,071
| +44% | +$28.7K | ﹤0.01% | 1046 |
|
|
2021
Q4 | $90K | Buy |
2,432
+322
| +15% | +$11.9K | ﹤0.01% | 1018 |
|
|
2021
Q3 | $101K | Buy |
2,110
+2,064
| +4,487% | +$98.8K | ﹤0.01% | 990 |
|
|
2021
Q2 | $2K | Hold |
46
| – | – | ﹤0.01% | 1129 |
|
|
2021
Q1 | $2K | Hold |
46
| – | – | ﹤0.01% | 1134 |
|
|
2020
Q4 | $2K | Buy |
+46
| New | +$2K | ﹤0.01% | 1108 |
|